| Ivan I Biley, MD | |
|
9205 Sw Barnes Rd, Mt 2800, Portland, OR 97225 | |
| (503) 216-2621 | |
| Not Available |
| Full Name | Ivan I Biley |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 9 Years |
| Location | 9205 Sw Barnes Rd, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073993069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD181351 (Oregon) | Secondary |
| 207R00000X | Internal Medicine | MD181351 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Portland Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
Women who received free meals in primary school have children with improved linear growth, according to a new study by researchers at the International Food Policy Research Institute.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.
The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now. Researchers at the Johns Hopkins University School of Medicine have now uncovered how a bacterial molecule controls the body's response to TB infection and suggest that adjusting the level of this of this molecule may be a new way to treat the disease.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 5 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
Women who received free meals in primary school have children with improved linear growth, according to a new study by researchers at the International Food Policy Research Institute.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.
The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now. Researchers at the Johns Hopkins University School of Medicine have now uncovered how a bacterial molecule controls the body's response to TB infection and suggest that adjusting the level of this of this molecule may be a new way to treat the disease.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 5 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
Women who received free meals in primary school have children with improved linear growth, according to a new study by researchers at the International Food Policy Research Institute.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.
The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now. Researchers at the Johns Hopkins University School of Medicine have now uncovered how a bacterial molecule controls the body's response to TB infection and suggest that adjusting the level of this of this molecule may be a new way to treat the disease.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 5 days ago
| Entity Name | Vibra Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659705424 PECOS PAC ID: 8921233933 Enrollment ID: O20140528001804 |
News Archive
Women who received free meals in primary school have children with improved linear growth, according to a new study by researchers at the International Food Policy Research Institute.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.
The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now. Researchers at the Johns Hopkins University School of Medicine have now uncovered how a bacterial molecule controls the body's response to TB infection and suggest that adjusting the level of this of this molecule may be a new way to treat the disease.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ivan I Biley, MD Po Box 3158, Portland, OR 97208-3158 Ph: () - | Ivan I Biley, MD 9205 Sw Barnes Rd, Mt 2800, Portland, OR 97225 Ph: (503) 216-2621 |
News Archive
Women who received free meals in primary school have children with improved linear growth, according to a new study by researchers at the International Food Policy Research Institute.
Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.
The latest challenge was a lawsuit filed Tuesday in Detroit's federal court by insurance giant Aetna, one of the nation's largest health plans, with 35 million members. The suit alleges a violation of federal antitrust laws, claiming the Blues raised rates for Michigan consumers over the last four years and used the money to reward hospitals with higher payments if they charged Blues' competitors the same or higher rates.
The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis have remained a mystery — until now. Researchers at the Johns Hopkins University School of Medicine have now uncovered how a bacterial molecule controls the body's response to TB infection and suggest that adjusting the level of this of this molecule may be a new way to treat the disease.
U.S. health regulators, the Food and Drugs Administration (FDA) has granted a priority review for an experimental Roche breast cancer drug that in clinical trials added six months to the time before the disease worsened. Pertuzumab approval decision is due by June 8th this year. It could be used with Herceptin in HER2-positive patients. This was announced by Roche Holding AG's Genentech unit on Tuesday.
› Verified 5 days ago
Salona Shrestha, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |